X-153935374-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_002910.6(RENBP):āc.1196T>Cā(p.Met399Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000531 in 1,128,918 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000090 ( 0 hom., 0 hem., cov: 24)
Exomes š: 0.0000049 ( 0 hom. 1 hem. )
Consequence
RENBP
NM_002910.6 missense
NM_002910.6 missense
Scores
1
6
10
Clinical Significance
Conservation
PhyloP100: 3.96
Genes affected
RENBP (HGNC:9959): (renin binding protein) The gene product inhibits renin activity by forming a dimer with renin, a complex known as high molecular weight renin. The encoded protein contains a leucine zipper domain, which is essential for its dimerization with renin. The gene product can catalyze the interconversion of N-acetylglucosamine to N-acetylmannosamine, indicating that it is a GlcNAc 2-epimerase. Transcript variants utilizing alternative promoters have been described in the literature. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.33305866).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RENBP | NM_002910.6 | c.1196T>C | p.Met399Thr | missense_variant | 11/11 | ENST00000393700.8 | NP_002901.2 | |
RENBP | XM_017029698.2 | c.1166T>C | p.Met389Thr | missense_variant | 11/11 | XP_016885187.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RENBP | ENST00000393700.8 | c.1196T>C | p.Met399Thr | missense_variant | 11/11 | 1 | NM_002910.6 | ENSP00000377303 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111620Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 33876
GnomAD3 genomes
AF:
AC:
2
AN:
111620
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
33876
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000187 AC: 2AN: 106983Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 30213
GnomAD3 exomes
AF:
AC:
2
AN:
106983
Hom.:
AF XY:
AC XY:
0
AN XY:
30213
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000492 AC: 5AN: 1017251Hom.: 0 Cov.: 27 AF XY: 0.00000312 AC XY: 1AN XY: 320793
GnomAD4 exome
AF:
AC:
5
AN:
1017251
Hom.:
Cov.:
27
AF XY:
AC XY:
1
AN XY:
320793
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000896 AC: 1AN: 111667Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 33933
GnomAD4 genome
AF:
AC:
1
AN:
111667
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
33933
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2021 | The c.1196T>C (p.M399T) alteration is located in exon 11 (coding exon 11) of the RENBP gene. This alteration results from a T to C substitution at nucleotide position 1196, causing the methionine (M) at amino acid position 399 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Benign
T;T;D
Sift4G
Uncertain
D;D;.
Polyphen
D;.;.
Vest4
MutPred
Gain of glycosylation at M399 (P = 0.0252);.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at